SCHEMBL9046994

SCHEMBL9046994

O=C([C@@H]1CCCN1C(=O)CC1Cc2ccccc2C1)N1CCC[C@H]1C=NO

nearest known ligand 0.67

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PREP P48147 17/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9047002 1.00 PREP (0.67) PREP
SCHEMBL9046610 0.95 PREP (0.69) PREP
SCHEMBL9046605 0.95 PREP (0.69) PREP
SCHEMBL7300341 0.90 PREP (0.74) PREP
SCHEMBL9047270 0.89 PREP (0.53) PREP
SCHEMBL9047276 0.89 PREP (0.53) PREP
SCHEMBL9051440 0.89 PREP (0.64) PREP
SCHEMBL9051437 0.89 PREP (0.64) PREP
SCHEMBL7298359 0.88 PREP (0.74) PREP
SCHEMBL9050257 0.88 PREP (0.51) PREP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0536399-B1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARM CO LTD (JP) 1996-01-24 EP disclosed
US-5407950-A Brain disorders, senile dementia ZERIA PHARMACEUTICAL CO., LTD. (JP) 1995-04-18 US disclosed
EP-0536399-A1 NOVEL ARYLALKANOYLAMINE DERIVATIVE AND DRUG CONTAINING THE SAME ZERIA PHARMACEUTICAL CO., LTD. (JP) 1993-04-14 EP disclosed